CARDIFF ONCOLOGY, INC. Long-term Line of Credit
CARDIFF ONCOLOGY, INC. (CRDF) had Long-term Line of Credit of $1.88 million as of 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:LineOfCredit · last filed 2016-11-09
- 2016-09-30: Long-term Line of Credit $1.88M.
- 2016-06-30: Long-term Line of Credit $1.88M.
- 2016-03-31: Long-term Line of Credit $1.64M.
- 2015-12-31: Long-term Line of Credit $1.09M.
| Period end | Long-term Line of Credit |
|---|---|
| 2016-09-30 | $1.88M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.88M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.64M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.09M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |